The formation of amyloid aggregates is a feature of most, if not all, polypeptide chains. In vivo modelling of this process has been undertaken in the fruitfly Drosophila melanogaster with remarkable success. Models of both neurological and systemic amyloid diseases have been generated and have informed our understanding of disease pathogenesis in two main ways. First, the toxic amyloid species have been at least partially characterized, for example in the case of the Aβ (amyloid β-peptide) associated with Alzheimer's disease. Secondly, the genetic underpinning of model disease-linked phenotypes has been characterized for a number of neurodegenerative disorders. The current challenge is to integrate our understanding of disease-linked processes in the fly with our growing knowledge of human disease, for the benefit of patients.
Review Article| August 18 2014
Insights into amyloid disease from fly models
Essays Biochem (2014) 56: 69–83.
- Views Icon Views
- Share Icon Share
Sarah Perrett, Ko-Fan Chen, Damian C. Crowther; Insights into amyloid disease from fly models. Essays Biochem 18 August 2014; 56 69–83. doi: https://doi.org/10.1042/bse0560069
Download citation file: